Abbonarsi

Real-time imaging of asthmatic epithelial cells identifies migratory deficiencies under type-2 conditions - 03/02/22

Doi : 10.1016/j.jaci.2021.08.027 
Mingzhu Jin, MD a, b, Simon Watkins, PhD c, Yolanda Larriba, PhD d, Callen Wallace, PhD c, Claudette St. Croix, PhD c, Xiuxia Zhou, PhD a, Jinming Zhao, PhD a, Shyamal Peddada, PhD e, Sally E. Wenzel, MD a, f,
a Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa 
b Department of Rhinology, Shengjing Hospital of China Medical University, Shenyang, China 
c Center for Biologic Imaging, School of Medicine, University of Pittsburgh, Pittsburgh, Pa 
d Department of Statistics and Operations Research, Universidad de Valladolid, Valladolid, Spain 
e Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa 
f University of Pittsburgh Asthma and Environmental Lung Health Institute @UPMC, Pittsburgh, Pa 

Corresponding author: Sally E. Wenzel, MD, 4127 Public Health, 130 Desoto Street, Pittsburgh, PA 15261.4127 Public Health130 Desoto StreetPittsburghPA15261

Abstract

Background

The epithelium is increasingly recognized as a pathologic contributor to asthma and its phenotypes. Although delayed wound closure by asthmatic epithelial cells is consistently observed, underlying mechanisms remain poorly understood, partly due to difficulties in studying dynamic physiologic processes involving polarized multilayered cell systems. Although type-2 immunity has been suggested to play a role, the mechanisms by which repair is diminished are unclear.

Objectives

This study sought to develop and utilize primary multilayered polarized epithelial cell systems, derived from patients with asthma, to evaluate cell migration in response to wounding under type-2 and untreated conditions.

Methods

A novel wounding device for multilayered polarized cells, along with time-lapse live cell/real-time confocal imaging were evaluated under IL-13 and untreated conditions. The influence of inhibition of 15 lipoxygenase (15LO1), a type-2 enzyme, on the process was also addressed. Cell migration patterns were analyzed by high-dimensional frequency modulated Möbius for statistical comparisons.

Results

IL-13 stimulation negatively impacts wound healing by altering the total speed, directionality, and acceleration of individual cells. Inhibition 15LO1 partially improved the wound repair through improving total speed.

Conclusions

Migration abnormalities contributed to markedly slower wound closure of IL-13 treated cells, which was modestly reversed by 15LO1 inhibition, suggesting its potential as an asthma therapeutic target. These novel methodologies offer new ways to dynamically study cell movements and identify contributing pathologic processes.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Key words : Asthma, airway epithelial cells, wound repair, cell migration, IL-13, type 2

Abbreviations used : 15LO1, AEC, ALI, AUC, BH, BLX, DMSO, Feno, FMM, MMA, T2


Mappa


 This study was supported by grants 1 R01 AI145406-01A1, 1 R01 HL153058-01, 5 P01 AI106684-05; and donations from the Dellenback family.
 Disclosure of potential conflict of interest: S. E. Wenzel declares additional unrelated conflicts of interest related to consulting with Sanofi (dupilumab), AstraZeneca (Tezepelumab), GSK (mepolizumab), and Knopp Bioscience (dexpramipexole); and multicenter research grants with AstraZeneca (Tezepelumab and Benralizumab), GSK (anti-IL33), and Knopp Bioscience (dexpramipexole). She has also received unrestricted research support for the Severe Asthma Research Program (unrelated to this study) from TEVA and Boehringer Ingelheim. She received institutional research support from Pieris. The rest of the authors declare that they have no relevant conflicts of interest.


© 2021  American Academy of Allergy, Asthma & Immunology. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 149 - N° 2

P. 579-588 - Febbraio 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
  • Amer Al-Musa, Brenna LaBere, Saddiq Habiballah, Alan A. Nguyen, Janet Chou
| Articolo seguente Articolo seguente
  • Neuroimaging and biomarker evidence of neurodegeneration in asthma
  • Melissa A. Rosenkranz, Douglas C. Dean, Barbara B. Bendlin, Nizar N. Jarjour, Stephane Esnault, Henrik Zetterberg, Amanda Heslegrave, Michael D. Evans, Richard J. Davidson, William W. Busse

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.